PPIB and osteogenesis imperfecta: Regarding CYPB, it has been reported that mutations in PPIB, leading to no protein production, lead to a more severe OI phenotype compared to mutations that result in protein alterations; it is unclear if this relates to the level of residual 3-hydroxyproline (Rush et al. 2014).